K-numberK243264
Device nameDHF 0.2 Hemoconcentrator (DHF 02); DHF 0.6 Hemoconcentrator (DHF 06); SH 14 Hemoconcentrator (SH 14)
ApplicantSorin Group Italia S.R.L.
Product codeKDI
Device classClass II
Decision dateApr 25, 2025
DecisionSubstantially Equivalent
Regulation876.5860
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The DHF 0.2, DHF 0.6, and SH 14 hemoconcentrators are single-use, sterile plastic devices designed for use in cardiopulmonary bypass circuits to remove fluid and restore the patient's normal red blood cell concentration (hematocrit). The choice of device depends on the filtration protocol and speed required, and each device is intended for use up to six hours.

Technological characteristics

The devices maintain the same fundamental technological characteristics, principles of operation, and control mechanisms as their predicate devices. The only design change is substitution of the O-ring elastomer material between the device housing and blood header caps from Santoprene to Silicone. The devices remain ethylene oxide sterilized with a non-pyrogenic fluid path for single use only.

Test standards cited

The DHF and SH hemoconcentrators comply with all applicable voluntary standards related to dialysers and passed all testing in accordance with national and international standards, though specific standard citations (ISO, IEC, ASTM) are not enumerated in this summary.

Substantial equivalence argument

The devices have identical intended use and technical characteristics to their predicate devices (K021732 for DHF models, K081313 for SH 14), differing only in the O-ring elastomer material, a change that does not alter the fundamental function or performance. Non-clinical verification and validation testing confirms compliance with applicable dialyser standards. Because the indications for use and core technological design are unchanged from predicates with several years of proven clinical safety and efficacy, no new safety or effectiveness questions are raised.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →